Cardiovascular Therapeutics

Toronto, Ontario, Canada, September 10, 2026 Cardiol Therapeutics Inc. has filed a US$150 million preliminary short form base shelf...

Shirley, New York, September 3, 2026 American Regent, Inc. has initiated a voluntary nationwide recall of three lots of...

San Francisco, California, September 3, 2026 Thryv Therapeutics Inc., a clinical-stage biopharmaceutical company developing selective SGK1 inhibitors, has entered...

Toronto, Ontario, January 16, 2026 — Cardiol Therapeutics announced a bought deal private placement financing for gross proceeds of...